Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000116

President & Immunovant CEO sold 200,000 shares at an average $35.11 ($7,022,668)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2026-10-20 Sale 10b5-1 −185,856 $35.09 $6,521,687 1,413,298 D: show line 1 in the form
Venker Eric President & Immunovant CEO 2026-10-20 Sale 10b5-1 −14,144 $35.42 $500,980 1,399,154 D: show line 2 in the form
Open-market sales · 200,000 sh · avg $35.11 · $7,022,668
Loading xslF345X06/wk-form4_1792709044.xml…